10 employees
Ventaleon is developing inhaled treatments against viral infections.
2012
Ventaleon GmbH raised undisclosed on January 1, 2015
Investors: Abalis Finance and LSP (Life Sciences Partners)
Ventaleon GmbH raised undisclosed on June 1, 2012
Investors: BayBG VENTURE CAPITAL